Drug Shortage Report for OMNIPAQUE 240

Last updated on 2021-10-27 History
Report ID 146048
Drug Identification Number 02172739
Brand name OMNIPAQUE 240
Common or Proper name iohexol injection USP
Company Name GE HEALTHCARE CANADA INC
Market Status MARKETED
Active Ingredient(s) IOHEXOL
Strength(s) 518MG
Dosage form(s) SOLUTION
Route of administration INTRAVASCULAR SUBARACHNOIDAL INTRAVASCULAR SUBARACHNOIDAL
Packaging size 20 mL
ATC code V08AB
ATC description X-RAY CONTRAST MEDIA, IODINATED
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-09-23
Estimated end date 2021-10-27
Actual end date 2021-10-26
Shortage status Resolved
Updated date 2021-10-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1919 MINNESOTA COURT
MISSISSAUGA, ONTARIO
CANADA L5N 0C9
Company contact information 800-387-7146 canadainfo@gehealthcare.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2021-10-27 English Compare
v10 2021-10-26 French Compare
v9 2021-10-26 English Compare
v8 2021-10-15 French Compare
v7 2021-10-15 English Compare
v6 2021-10-07 French Compare
v5 2021-10-07 English Compare
v4 2021-10-07 English Compare
v3 2021-09-24 English Compare
v2 2021-09-23 French Compare
v1 2021-09-23 English Compare

Showing 1 to 11 of 11